William John Sibold
CEO, President at Madrigal Pharmaceuticals, Inc. (MDGL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $10.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 131209,198 held (−0%) | $527.88 | $69K | -10.6% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 347208,851 held (−0%) | $529.27 | $184K | -10.9% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 522208,329 held (−0%) | $530.23 | $277K | -11.0% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 368207,961 held (−0%) | $531.99 | $196K | -11.3% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 512207,449 held (−0%) | $533.09 | $273K | -11.5% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 396207,053 held (−0%) | $534.20 | $212K | -11.7% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 644206,409 held (−0%) | $535.27 | $345K | -11.9% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,040205,369 held (−1%) | $536.11 | $558K | -12.0% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 640204,729 held (−0%) | $537.17 | $344K | -12.2% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 520204,209 held (−0%) | $538.30 | $280K | -12.4% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 215203,994 held (−0%) | $539.03 | $116K | -12.5% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 505203,489 held (−0%) | $540.19 | $273K | -12.7% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 362203,127 held (−0%) | $541.65 | $196K | -12.9% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 160202,967 held (−0%) | $542.55 | $87K | -13.0% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 60202,907 held (−0%) | $533.09 | $32K | -11.5% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 106202,801 held (−0%) | $534.06 | $57K | -11.7% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 218202,583 held (−0%) | $535.94 | $117K | -12.0% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 160202,423 held (−0%) | $537.62 | $86K | -12.3% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 687201,736 held (−0%) | $540.59 | $371K | -12.7% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 368201,368 held (−0%) | $541.64 | $199K | -12.9% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,202200,166 held (−1%) | $542.60 | $652K | -13.1% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,539198,627 held (−1%) | $544.02 | $837K | -13.3% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 761197,866 held (−0%) | $544.83 | $415K | -13.4% |
| Sep 11SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 120197,746 held (−0%) | $546.38 | $66K | -13.7% |
| Jul 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 140211,689 held (−0%) | $542.75 | $76K | -13.1% |
| Jul 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 110211,579 held (−0%) | $543.79 | $60K | -13.2% |
| Jul 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 545211,034 held (−0%) | $544.71 | $297K | -13.4% |
| Jul 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 275210,759 held (−0%) | $545.71 | $150K | -13.6% |
| Jul 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 269210,490 held (−0%) | $547.08 | $147K | -13.8% |
| Jul 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 680209,810 held (−0%) | $547.70 | $372K | -13.9% |
| Jul 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 47209,763 held (−0%) | $548.87 | $26K | -14.1% |
| Jul 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 153209,610 held (−0%) | $550.01 | $84K | -14.2% |
| Jul 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 1209,609 held (−0%) | $550.72 | $551 | -14.3% |
| Jul 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 280209,329 held (−0%) | $555.05 | $155K | -15.0% |
| Mar 6SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 1,663161,829 held (−1%) | $431.94 | $718K | +9.2% |
| Jan 26SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 1,577148,497 held (−1%) | $492.42 | $777K | -4.2% |
| Dec 4SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 2,400150,074 held (−2%) | $575.34 | $1.4M | -18.0% |
- Sell
CEO, President William John Sibold sold $69K of MDGL at $527.88 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President William John Sibold sold $184K of MDGL at $529.27 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President William John Sibold sold $277K of MDGL at $530.23 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President William John Sibold sold $196K of MDGL at $531.99 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President William John Sibold sold $273K of MDGL at $533.09 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President William John Sibold sold $212K of MDGL at $534.20 — pre-scheduled 10b5-1 plan sale.